Epigenetic Biomarker for Osteosarcoma

Clinical trial NCT03336554 · UNKNOWN

Trial details

NCT number: NCT03336554
Sponsor: Peking University People's Hospital
Status: UNKNOWN
Study type: OBSERVATIONAL

Histologic Response (Tumor Necrosis Rate)Objective Response Rate for Neoadjuvant Chemotherapy, ORR Progression-free Survival, PFS Overall Survival, OS

Start date: 2017-09-01
Primary completion: 2018-10-30
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.